Beximco Pharmaceuticals PLC. (BST:R2WA)
Germany
· Delayed Price · Currency is EUR 0.458
+0.008 (1.78%)
At close: Dec 5, 2025
BST:R2WA Revenue
Beximco Pharmaceuticals PLC. had revenue of 12.30B BDT in the quarter ending December 31, 2024, with 12.80% growth. This brings the company's revenue in the last twelve months to 46.34B, up 11.26% year-over-year. In the fiscal year ending June 30, 2024, Beximco Pharmaceuticals PLC. had annual revenue of 44.39B with 13.05% growth.
Revenue (ttm)
46.34B BDT
Revenue Growth
+11.26%
P/S Ratio
0.92
Revenue / Employee
41.30M BDT
Employees
1,122
Market Cap
345.13M EUR
Revenue Chart
* This company reports financials in BDT.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 44.39B | 5.12B | 13.05% |
| Jun 30, 2023 | 39.27B | 4.60B | 13.26% |
| Jun 30, 2022 | 34.67B | 5.18B | 17.55% |
| Jun 30, 2021 | 29.49B | 3.88B | 15.16% |
| Jun 30, 2020 | 25.61B | 2.80B | 12.25% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |